chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse event; expired vaccine was administered  to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered  to patient) and NO ADVERSE EVENT (No adverse event) in a 55-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7185B) for COVID-19 prophylaxis.     Medical History or Condition for the patient was not reported. The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for COVID-19 prophylaxis: MODERNA COVID-19 VACCINE (dose 1 and  lot number was 031H21A) on 26-Nov-2021; for COVID-19 vaccination: COVID-19 VACCINE (dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE and MODERNA COVID-19 VACCINE.    On 13-Jun-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 13-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered  to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered  to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered  to patient).    No concomitant medication was reported. It was reported that 4 expired vaccines were administered to 4 different patients. It was reported that the vaccine been expired about 8 or more days. Patient was not aware that he received an expired dose. No treatment medication was reported.  This case contains information about patient 2nd out of 4 patients.   Reporter did not allow further contact
Woke up the following morning with nausea and chills followed by muscle stiffness and joint pain.
Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.            No concomitant medications were reported. No treatment medication were reported. This case concerns a male patient of an unknown age with no relevant medical history, who experienced the unexpected event of Pain in Extremity. The event occurred on an unknown date after receiving an unknown dose number of mRNA-1273 Vaccine. The rechallenge was not applicable since no information about the dose number was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This case concerns a male patient of an unknown age with no relevant medical history, who experienced the unexpected event of Pain in Extremity. The event occurred on an unknown date after receiving an unknown dose number of mRNA-1273 Vaccine. The rechallenge was not applicable since no information about the dose number was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
My booster was 10/17/2022. By 12/18/2022, I lost my sense of taste. I feel like I always have a metal taste in my mouth. I can taste salty better than sweet, but normal things that should taste good do not. I've never had this issue before. Between the time of getting my booster and having this symptom, I did have cold, but it was not COVID-19. I tested myself for COVID-19 and I took a second COVID-19 test as well and both were negative. It was around 12/10/2022, that I developed my cold and then it was around 6 or 7 days later when I developed this taste issue. I was also at this time, experiencing a little tingling in my right and a bit in my left. I went to the doctor, and they had no explanation for it. They did a blood test, and everything was normal. I have looked up loss of taste and cannot find anything that makes sense that could be causing this. I have no idea if this is related to the booster. I had COVID-19 in May of 2022.
Information has been received from a physician concerning a 15 month old male patient who in approximately July 2003, was vaccinated with a first dose of MMR II. Subsequently, in approximately JUL-2003, the patient experienced a systemic rash located all over their body. The patient fully recovered. No product quality complaint was involved. Additional information has been requested.
Patient reported arm pain and numbness immediately following vaccine. The pain turned to stiffness and limited motion of raising the arm (right). She approached her doctor about a month later and he started her on physical therapy. The use and motion has improved, but the pain is still present.
Started feeling shortness of breath and cough 12-14 hours after taking the booster. Ended up being in an urgent care on 10/11/2021. Was put on sever asthma treatment plan. Didn't help much. Ended up being in ER on 10/18/2021 with severe asthma attack. Was given treatment and put on Prednisone and inhalers. This helps as long as I am on these medicines. As soon as I am taken off, shortness of breath and cough starts building back.
8/24/2000 - Telephone call from grandmother states patient received Hep B vax #3 and varicella on 7/20/2000 at approximately 11:30 am. Stated that around 2-3 pm patient came in from playing outside; stated he felt tired. Grandmother noted at that time patients neck was swollen.
Incredible, sudden pain in ankles the next day (could not stand) independent of any other injury  visited multiple podiatrists with no agreed-on cause or diagnosis
This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a female patient who received SHINGRIX for prophylaxis. On 20th September 2018, the patient received the 1st dose of SHINGRIX (subcutaneous). In September 2018, less than a month after receiving SHINGRIX, the patient experienced adverse reaction. On 20th September 2018, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the adverse reaction and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On Thursday, the patient received the dose of shingles vaccine subcutaneously instead of intramuscular by the pharmacist, which led to inappropriate route of vaccination. The patient's primary care doctor had already taken the proper steps to report this and treated her for the adverse reaction. The patient had question that what would be the impact, if any, would the error have impact on the efficacy of the first dose.
Pt called next am and  complained of severe dizziness. I discussed with patient about purchasing OTC meclizine. She did so and in speaking with her later in the day she was doing much better. I spoke again with her on 12/24 and she said she was "almost well".
Felt difficulty breathing, vasovagal event - weakness, Epi-pen 0.3mg x1, called 911, paramedics took her to Arcadia Methodist.
This spontaneous report as received from a 78 year old female patient regarding herself. There were no concurrent conditions, medical history or allergy/drug reactions. On 27-JAN-2016 the patient was vaccinated once with ZOSTAVAX injection (lot reported as L035504, expiry date: 16-DEC-2016) subcutaneously under the arm where the fat hangs down. Patient had no concomitant medications. On 29-JAN-2016 after receiving the vaccination the patient experienced rash which got worse. Approximately on 31-JAN-2016 (reported as Sunday) it was all over her back and was very itchy. The rash was also on her arms and chest. The patient sought medical attention which included an office visit on 01-FEB-2016. Treatment included unspecified shingles medication. Lab diagnostics studies were not performed. The outcome of the events was reported as not recovered/not resolved. The reporter did not provide the causality between the event and the suspect therapy. There were no product quality complaints (PQC) involved. Additional information has been requested.
Local reaction, fever, arthralgias, myalgias and vomiting on day of administration Persistent arthralgias since then involving left shoulder, right hip, right knee and to a lesser extent left wrist, persisting until today Painful, erythematous left axillary mass that started 11/9/2021
Muscle ache, high fever, muscle ache, terrible headache, nausea, shortness of breath. The worst symptoms stopped within 48 hours but constant  muscle ache and stiffness lasted two weeks after second shot.
LEFT SUBCLAVIAN STEAL SYNDROME ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
breaking out in hives; redness around the eye; thumb is in pain; Rash on the arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (breaking out in hives), OCULAR HYPERAEMIA (redness around the eye), PAIN IN EXTREMITY (thumb is in pain) and RASH (Rash on the arm) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (breaking out in hives), OCULAR HYPERAEMIA (redness around the eye), PAIN IN EXTREMITY (thumb is in pain) and RASH (Rash on the arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, URTICARIA (breaking out in hives), OCULAR HYPERAEMIA (redness around the eye), PAIN IN EXTREMITY (thumb is in pain) and RASH (Rash on the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Information has been received from a physician concerning a female patient who completed the series for GARDASIL. On an unspecified date, the patient was HPV positive. The outcome of the patient was not reported. Additional information is expected.
first vaccine was two months ago. Can I still get the second; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first vaccine was two months ago. Can I still get the second) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first vaccine was two months ago. Can I still get the second). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first vaccine was two months ago. Can I still get the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       there are no treatment and concomitant medications given no previous history given..
5 minutes after administration of vaccine, patient was found to have 1 solitary hive below site of MMR vaccine. Hive about 3x3cm with central area of 1x1cm. No other systemic symptoms.
Sore arm, extreme chills, achiness, low grade fever (100.9) and fatigue, all lasting 24 hours. Took Advil for fever and achiness twice during that time course.
The patient fainted for about 5 seconds after administration of Moderna vaccine (booster 0.25mL).  The patient stated he has history of fainting after receiving flu shot, but he did not disclose it when he answered the screening questions. After recovery, patient was given 2 bottles of water and was monitored by the LPN from the clinic. Blood pressure at the time of transfer to clinic observation waiting room was 110/78, pulse 74. Patient released about 15 minutes after complete recovery. I called the patient around 06:30 pm to check on him. He said he was doing perfectly.
Pt received first dose of COVID-19 vaccine Moderna today at approximately 8:17am. Pt was observed for 15 minutes post-vaccine administration with no complaints. Pt reports an hour later developed a change of sensation to bilateral cheeks and around the mouth. Described it as a "tingling like coming off novovaine." Denes redness, swelling, weakness in the face or slurring of words. Reports lasting for about an hour or so and resolved completely without intervention. Pt returned to clinic for evaluation by physician without any current symptoms. BP 121/81 HR 73 RR 16 SPo2 98% on RA. CN 2-12 intact/symmetric. No increased work of breathing, speaks in full sentences.
Pt felt faint, was pale and diaphoretic, no seizure like movements per father, was observed 20 min post incident pt felt fine, parents took her home.
This spontaneous report was received from an office manager concerning a 7-year-old patient of unknown gender and ethnicity. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On an unknown date, the patient was inadvertently vaccinated with the first dose of GARDASIL (dose, lot number, expiration date and route of administration were not reported). The patient did not seek medical attention. The second and third dose of GARDASIL have not been administered to the patient. No adverse effects reported. Additional information has been requested.
During the 15 minute respite the patient appeared to have a primary cardiac event and rolled forward off their chair onto the floor. Hitting their nose causing significant bleeding.   911 was immediately called  Found to be pulseless, CPR was initiated within 30 seconds of event. Patient received 2 rounds of CPR, 1 AED shock, 1 mg Epi, Oral airway placed, High flow O2 with Bag Mask. ROSC returning in approximately 3+ minutes. Patient was able to talk appropriately after ROSC minus some coughing due to postnasal blood. Patient was transferred via EMS to local ED for cardiac workup. Code was run by Cardiac Surgeon, National Guard EMTs, Redmond Fire Paramedics
Excruciating pain, no range of motion, could not sleep at all, shivering from pain, took Tylenol to no avail, applied ice and heat to no avail.
On 1/14/2021 resident began having a loose nonproductive cough. Lungs clear. Increased shortness of breath, Afebrile. Complaints of Left sided rib pain. Resident currently on hospice. Started Duonebs every 6 hrs. Resident also began having loose stools as well.
Beginning the next day, I started to experience an achy feeling in my upper arm, it traveled down to my lower arm, then by the net day i felt the aching feeling in my wrist.  It then went into my other right arm by 3 days post shot.  Now all of my joints ache and are uncomfortable all the time (legs and arms).  I am having issues picking up heavy items without pain. I feel like I am swollen in all of my joints.  I otherwise feel great
pt recvd vax & exp severe h/a overnoc; sx resolved w/o treatment; MD feels that this sx was unrelated to the pt's ventricular septal defect; vax series discontinued;
there have been no additional adverse experiences reported; an improperly stored vaccine was administered to a patient; This spontaneous report was received from a physician referring to a 4-year-old patient. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not provided.  On 12-JAN-2023, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 1 dosage form, administered for prophylaxis (lot# W024966 with an expiration date on 05-FEB-2024) (strength, anatomical location and route of administration were not provided).  The dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was exposed to a temperature excursion of 10 degrees Celsius (°C) during a time frame of 1 hour 28 minutes (product storage error). No previous temperature excursion was reported.  There have been no additional adverse experiences reported. No product quality complaints reported.          ?
Around 8:30pm I had halo in my vision- I took my contacts out and out glasses on it went away shortly after that.  Around 9:00pm started chills and aching.  Around 9:30 headache & arm sore  vaccine area   All these symptoms lasted through the night., I tossed and turned up getting drinks of water. Woke the next morning with headache & body aches. The chills where gone.  Took excedrine headache started to subside  still ache & started feeling nauseous. Felt like this most of the day.  Slept fine the night of the 17th.  Woke 18th feeling very tired but most of the other symptoms gone.  Arm  still sore from vaccine  Hoping tomorrow to feel 100% again.
she had Mild pain at injection site; she discovered she has a swollen lymph node near her collar bone; This is a spontaneous report from a contactable consumer received via a Pfizer sales representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL9269), via an unspecified route of administration on 09Feb2021 as a single dose for COVID-19 immunization. The patient's medical history included hypothyroidism. Concomitant medication included: levothyroxine sodium (SYNTHROID) taken for hypothyroidism, start and stop date were not reported. The patient received the first shot on Tuesday 09Feb2021. She had mild pain at injection site. She was doing great. But today Friday 12Feb2021, she discovered she had a swollen lymph node near her collar bone. The outcome of the events was unknown.  No follow-up attempts are possible. No further Information expected.
The following day I had dizziness and vomiting May/5. Two weeks later I felt like I was having muscle spasm and I couldn't breathe properly. It reached the point where I couldn't bend over. I went to an ER on May 18th around 9 or 10 at night. When I lied down, I had a fast heart pace. I was admitted for overnight. I was home by noon the next day. They checked the enzymes that you build after a heart attack. They were mainly focused that I wasn't having a heart attack. I had a lot of fluids released after an hour of being in the ER. I had about 600ml every 10 minutes all night long. My wrist and legs were puffy, and as I released fluids, I noticed that going down. I had heart palpitations. They gave me potassium due to it being low. I saw my doctor on 24th of May at 4PM. She put me on a water pill that I'm still on. My heart went over 110. They filed a medical exemption so that I wouldn't get the second vaccine. The next visit with her she put me on hydrochloride once a day. She also gave me compression stockings to help with the swelling.
Case number PHEH2013US020956 is an initial spontaneous report received from the medical assistant on 04 Oct 2013 with a follow up information received from the medical assistant on 05 Nov 2013. This report refers to a female child patient who was of 11-12 years of age. She had no recent injury, no allergic reactions and allergy to medications. She had a history of lactose intolerance, intestinal disaccharide deficiency and vitiligo. Her current conditions included sore throat, cough, congestion, headache and watery eyes and concomitant medications were not reported. Her vaccination history included administration of varicella virus vaccine (other manufacturer, batch number: not reported), MMR (other manufacturer, batch number: not reported) and HIB-PRP-T (other manufacturer, batch number: not reported) on 08 Nov 2002, DTaP (other manufacturer, batch number: not reported) and PCV13 (other manufacturer, batch number: not reported) on 31 Jan 2003, hepatitis A vaccine (other manufacturer, batch number: not reported), varicella vaccine (other manufacturer, batch number: not reported), DTaP (other manufacturer, batch number: not reported) and MMR (other manufacturer, batch number: not reported) on 23 Mar 2007, hepatitis A vaccine (other manufacturer, batch number: not reported) on 06 Aug 2009, H1N1 flu vaccine (unknown manufacturer, batch number: not reported) in 23 Nov 2009 and seasonal influenza vaccine (unknown manufacturer, batch number: not reported) in 23 Dec 2009. She was vaccinated with 0.5 ml of MENVEO (batch number: A12114, expiry date: 31 Aug 2014) intramuscularly in the right arm on 03 Oct 2013. She also received influenza vaccine (other manufacturer, batch number: UHB99AA, expiry date: 30 Jun 2014) and Tdap (other manufacturer, batch number: U4617AA, expiry date: 22 Oct 2015) on the same date. On an unknown date after vaccination, she experienced lightheadedness and dizziness. Her vital signs were checked and were normal. Physical examination was done and the findings were normal. The events outcome was reported as complete recovery. The seriousness and causality were not reported. No additional information was available. Follow up information received from the medical assistant on 05 Nov 2013: Patient demographics (height and weight), laboratory data, vaccination history, suspect vaccines, site of vaccination, outcome of the event updated.
After patients second covid vaccine on 4/9/21. Patient began vomiting on 4/10/21. Patient had extreme stomach pain and non stop vomiting. Patient went to ER. Patient was given IV fluids, meds for vomiting, sent home. On 4/12/21, the vomiting and stomach pain continued. Back to ER. Patient was discharged home. Symptoms worsened. Patient was then taken by EMS to ER for second time on 4/12/21. On 4/13/21 patient woke with vomiting and stomach pain. Was seen in ER again.
Caller stated she's still hurting from the first shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 30Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Caller stated she's still hurting from the first shot". Therapeutic measures were taken as a result of pain.  Additional information: The patient received first dose of Pfizer's COVID vaccine on Friday. The HCP told her not to take ibuprofen right away but she didn't specify how many days after the shot she could start taking it again. The patient was asking when she could start taking ibuprofen. The patient stated that she was still hurting from the first shot and she had been taking Tylenol.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I went to the emergency room  04/15/2021 because I had a rash all over my body. Dr prescribed me steroids for 10 days.